
A Population Pharmacokinetics Study of Venetoclax Concomitant with Voriconazole in Patients with Hematologic ...
Introduction Venetoclax is a first-in-class, orally bioavailable selective B cell lymphoma 2 (BCL-2) inhibitor that induces apoptosis in malignant cells.1 Currently, it has been approved in several countries for treating chronic lymphocytic leukemia (CLL), …